As a result, dose adjustment in individuals with renal insufficiency or ESRD may be expected (Desk three and Table 12). Decreasing the dose lowers peak serum drug concentrations and can compromise treatment efficacy. Dependant on specialist impression, the interval involving drug doses in clients with a creatinine clearance of thirty mL/min creatin